Home Weight loss (GLP-1) By state Louisiana
Louisiana's Act 898 Waits on Funding: 5 programs ship to LA
Louisiana is a state where compounded semaglutide can be hard to get. The state pharmacy board moved against salt-form semaglutide in 2023, and several online programs no longer serve the state. A 2026 law promises Medicaid coverage of weight-loss drugs, but only once the Legislature pays for it. You still have options: several online programs serve Louisiana with compounded tirzepatide and the other medications they list for the state. The lowest price we found from a program that ships to Louisiana: compounded semaglutide at $89 a month on a 12-month plan ($99 month to month) at Lttl.
Louisiana at a glance
- Louisiana Medicaid
- Does not cover for weight loss
- State employee plan
- Does not cover for weight loss
- Adults with obesity
- 35.6% (2025)
- Programs we compare that ship to LA
- 5 of 22
Good to know in Louisiana: Louisiana limits compounded semaglutide shipped into the state, so several programs skip Louisiana; ask about tirzepatide or brand-name options. The programs below say they serve Louisiana.
Online GLP-1 programs for Louisiana, cheapest first
Programs that ship to Louisiana. Prescribed online by a licensed clinician; medication and delivery included.
How we pick and check programs
Our pick for November 2026

Choose weekly shots or daily tablets; shots from $99/mo on the 12-month plan
Compounded semaglutide in Louisiana: lowest monthly price
| # | Program | Lowest price | Month to month | Link |
|---|---|---|---|---|
| 1 | LttlCheapest | $89/mo 12-month plan | $99 / 4 wks | VisitLttl |
| 2 | BetterMe Rx | $99/mo 12-month plan | $199/mo | VisitBetterMe Rx |
| 3 | Refills | $99/mo | $99 / 4 wks | VisitRefills |
| 4 | Gala | From $69/mo starting price, plan length not stated | Not stated | VisitGala |
| 5 | TrimRx | From $349/mo starting price, plan length not stated | Not stated | VisitTrimRx |
Compounded tirzepatide in Louisiana: lowest monthly price
| # | Program | Lowest price | Month to month | Link |
|---|---|---|---|---|
| 1 | LttlCheapest | $139/mo 12-month plan | $149 / 4 wks | VisitLttl |
| 2 | BetterMe Rx | $159/mo 12-month plan | $249/mo | VisitBetterMe Rx |
| 3 | Refills | $159/mo | $159 / 4 wks | VisitRefills |
| 4 | Gala | From $99/mo starting price, plan length not stated | Not stated | VisitGala |
| 5 | TrimRx | From $279/mo starting price, plan length not stated | Not stated | VisitTrimRx |
- Low month-to-month#1
Up to $140 off your first monthCompounded semaglutide for $99, month to month
Semaglutide$99/momonth to month (4-week supply); $89 on a 12-month planVisit Lttl Read our Lttl review - Pills or shots#2
Semaglutide from $99/moChoose weekly shots or daily tablets; shots from $99/mo on the 12-month plan
Semaglutide shots from$99/moon the 12-month plan; $199 month to monthVisit BetterMe Rx Read our BetterMe Rx review - No contract#3
Fall sale: 40% offCompounded semaglutide as low as $99 a month
Semaglutide as low as$99/moper 4-week supply, month to month; shown during a 40% fall sale4.2 on Trustpilot1,779 reviews ·Visit Refills Read our Refills review - Rated 4.6 on Trustpilot#4
Price locked at every doseOne low GLP-1 price, from dose one to maintenance
Semaglutide from$69/mo"starting at"; Gala's weight-loss page shows semaglutide from $129 and tirzepatide from $179; final price at checkout4.6 on Trustpilot4,257 reviews ·Visit Gala Read our Gala review - Guaranteed pricing#5
Get started for $179Keep your dose. No surprises, no price hikes
Semaglutide from$179/mo"starting at"; its semaglutide page shows $179 as the oral program's first month (regular $329) and shots at $199 for the first month (regular $349)Visit TrimRx Read our TrimRx review
Why semaglutide is harder to find in Louisiana
In spring 2023, NBC News reported, the Louisiana Board of Pharmacy was among four state boards that told pharmacies to stop compounding with unapproved salt forms of semaglutide. Later that year the Board fined a Baton Rouge pharmacy $35,700 for dispensing 2,380 prescriptions made with semaglutide sodium, a form the FDA had not approved.
Since then, some national programs have left Louisiana out of their service area, and others list only certain medications here. That is why the program list on this page is shorter than in most states. We show only programs that say on their own site that they serve Louisiana, and you should still ask which medications a program can send here before you pay.
So if you pay cash here, tirzepatide programs are worth a look. The programs in our list each show their own monthly price. If you want a brand-name drug such as Wegovy or Zepbound instead, ask during intake whether the program can prescribe it to a Louisiana address.
- The Louisiana Board of Pharmacy fined a Baton Rouge pharmacy $35,700 in 2023 for dispensing 2,380 prescriptions using non-FDA-approved semaglutide sodium (Board newsletter, October 2023). (nabp.pharmacy)
- Act 898 of 2026 (SB 433, Boudreaux) requires Medicaid coverage of medically necessary FDA-approved weight-loss drugs under LDH criteria, allows prior authorization, prohibits step therapy, and is effective June 9, 2026 and upon appropriation by the Legislature. (legis.la.gov)
- Louisiana Medicaid spends about $240 million a year on GLP-1s for conditions such as diabetes and liver disease, per LDH; Secretary Bruce Greenstein put the added cost of obesity coverage at about $60 million (Fox 8, May 2026). (fox8live.com)
- LDH's Zepbound criteria require age 18+, moderate to severe OSA with AHI 15 or more on a sleep study within 12 months, BMI 30 or more, no type 1 or type 2 diabetes, and a treatment agreement; renewal looks at 5% weight loss and sleep apnea response. (ldh.la.gov)
- Louisiana Medicaid's single preferred drug list applies to fee-for-service members and to members of every managed care organization. (ldh.la.gov)
- KFF's January 2026 review lists Louisiana Medicaid among the states that cover one or more weight-loss drugs but no GLP-1s for obesity. (kff.org)
- The Office of Group Benefits' 2026 Pelican HRA 1000 plan document excludes medications for obesity and weight loss (it names Saxenda and Zepbound) unless the Schedule of Benefits shows them as covered. (web.archive.org)
- Louisiana's adult obesity rate was 35.6% in 2025. (cdc.gov)
Act 898: Medicaid coverage on paper, pending a budget line
SB 433 by Sen. Gerald Boudreaux of Lafayette became Act 898 of the 2026 regular session. It requires Louisiana Medicaid to cover FDA-approved weight loss medications that are medically necessary, for members who meet criteria the Louisiana Department of Health sets. Prior authorization is allowed. Step therapy, where you must fail a cheaper drug first, is banned.
The catch is in the effective date: June 9, 2026, and upon appropriation of funds by the Legislature. Until lawmakers fund it, nothing changes at the pharmacy counter. At an April 27 Senate Finance Committee hearing, Health Secretary Bruce Greenstein backed the bill and, Fox 8 reported, put the extra cost at about $60 million, on top of the roughly $240 million a year the program already spends on GLP-1s for conditions such as diabetes and liver disease. With about 1.4 million people enrolled, the decision affects a large share of the state.
Healthy Louisiana today: one drug list, sleep apnea criteria for Zepbound
Louisiana Medicaid uses a single preferred drug list for fee-for-service and every Healthy Louisiana managed care plan, so switching plans does not change which GLP-1s are covered. KFF's January 2026 review puts Louisiana among the states that cover one or more weight-loss drugs but no GLP-1s for obesity.
Zepbound can be approved for obstructive sleep apnea. LDH's criteria require an adult with moderate to severe sleep apnea, an apnea-hypopnea index of 15 or more on a sleep study from the past 12 months, a BMI of 30 or more, no type 1 or type 2 diabetes, and a signed treatment agreement. To continue, the prescriber must show at least 5% weight loss or explain why treatment should go on, plus improvement in sleep apnea.
If you don't have sleep apnea or diabetes, Medicaid won't pay for a GLP-1 until Act 898 is funded. A cash program is the way to start now.
GLP-1 in Louisiana: questions
Does Louisiana Medicaid pay for Wegovy yet?
Not yet. Act 898, effective June 9, 2026, requires Medicaid to cover FDA-approved weight-loss drugs, but only once the Legislature funds it. Until then, Louisiana Medicaid covers GLP-1s for conditions such as type 2 diabetes, and Zepbound for sleep apnea with prior authorization. If you want to start now, a cash program from our list can begin with an online visit.
What are Louisiana Medicaid's criteria for Zepbound?
Zepbound is reviewed for sleep apnea, not weight alone. LDH asks for an adult with moderate to severe sleep apnea, an AHI of 15 or more on a sleep study in the past year, a BMI of 30 or more, no diabetes, and a signed treatment agreement. Renewal needs proof the drug is helping. Without sleep apnea, self-pay is the route.
Can I still get compounded semaglutide shipped to Louisiana?
Many programs will not ship it here. The Louisiana Board of Pharmacy moved against compounded semaglutide in 2023 over salt forms, and several national programs now exclude the state. Programs that serve the state often offer tirzepatide. The list on this page shows programs confirmed to serve Louisiana.
Do Louisiana state employees on OGB get weight-loss drugs covered?
Not for weight loss under the plan document we read. OGB's 2026 Pelican HRA 1000 plan document excludes medications for obesity and weight loss, naming Saxenda and Zepbound, unless its Schedule of Benefits lists them. Other OGB plans have their own documents, so check yours. GLP-1s prescribed for diabetes follow the normal drug benefit. State workers who want a GLP-1 for weight loss pay out of pocket, and can compare the online programs on this page.
What does compounded tirzepatide cost in Louisiana?
In November 2026, Lttl, which serves Louisiana, listed it at $139 a month on a 12-month plan, with the same price at every dose. Gala, which also serves Louisiana, listed it from $99 a month (starting price; plan length not stated). Other programs in our list price it differently, and some raise the price as the dose goes up. Compare the monthly cost at the dose you expect to reach.
Is a GLP-1 pill an option in Louisiana?
Possibly. Brand-name pills such as the Wegovy pill and Foundayo are FDA-approved for weight loss, and because they are not compounded, the Louisiana compounding rules do not apply to them. Ask the programs in our Louisiana list which pills, if any, they can prescribe and ship here. You still need a prescription, which the program's clinician writes after an online review.
See programs for Louisiana All states
Sources: kff.org · cdc.gov · web.archive.org · nabp.pharmacy